02-14-2023 | Obesity | News
There is a “substantial” burden of overweight and obesity among people with type 1 diabetes, say US researchers who found rates to be in line with that of the general population.
11-01-2022 | SGLT2 inhibitors | News
People with type 1 diabetes who take GLP-1 receptor agonists or SGLT2 inhibitors in clinical practice have outcomes that are mostly – but not all – in line with those in controlled trials, say researchers.
10-10-2022 | Semaglutide | News
The substantial weight loss achieved with weekly semaglutide 2.4 mg is maintained if people continue to take the medication for 2 years, show the STEP 5 results.
Get the latest results and insights from the researchers.
06-05-2023 | Prediabetes | News
05-04-2023 | Diet | News
04-25-2023 | Diet | News
Primary findings, 2-year outcomes and translating this landmark trial into practice
01-17-2023 | Lifestyle interventions | News
01-16-2023 | Diet | News
01-09-2023 | Semaglutide | News
12-19-2022 | Early onset | News
12-16-2022 | Diet | News
12-13-2022 | Diet | News
12-01-2022 | Semaglutide | News
Get the latest developments in diabetes delivered straight to your inbox